Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2020-11-25 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Reply Slip for the Third Extraordinary General Meeting of 2020 (Applicable to H Shareholders)
Regulatory Filings Classification · 95% confidence The document is a 'Reply Slip' for an Extraordinary General Meeting (EGM) of Pharmaron Beijing Co., Ltd. It is a form for shareholders to confirm attendance at the EGM. The content is procedural and related to shareholder meeting logistics, not a report or announcement of voting results. It is not a full report, financial statement, or management discussion. Given the nature of the document as a meeting attendance confirmation, it aligns most closely with materials related to shareholder meetings but is not the AGM Information presentation itself. It is also not a Proxy Solicitation or Voting Results announcement. Since it is a procedural document related to a shareholder meeting, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory documents that do not fit other categories.
2020-11-25 English
Proxy Form for the Solicitation of Voting Rights by Independent Non-Executive Director ("Independent Director's Proxy Form") for the Second H Shares Class Meeting of 2020
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for the solicitation of voting rights by an independent non-executive director for a specific class meeting of shareholders. It includes instructions for shareholders on how to appoint a proxy and vote on special resolutions related to a restricted share incentive scheme. The document is clearly related to shareholder voting procedures and proxy solicitation rather than the actual meeting materials, voting results, or financial reports. Therefore, it fits best under the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2020-11-25 English
Proxy Form for the Solicitation of Voting Rights by Independent Non-Executive Director ("Independent Director's Proxy Form") for the Third Extraordinary General Meeting of 2020
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for the solicitation of voting rights by an independent non-executive director for an Extraordinary General Meeting (EGM) of Pharmaron Beijing Co., Ltd. It includes instructions for shareholders to appoint a proxy and vote on specific resolutions related to a restricted share incentive scheme. The content is focused on voting procedures and proxy appointment rather than the actual meeting materials or voting results. This type of document is used to solicit votes and provide shareholders with the means to vote by proxy, which fits the definition of Proxy Solicitation & Information Statement (PSI). The document is not a report of voting results (DVA), nor is it a notice or announcement of a meeting (RPA). It is also not a full report or financial statement. Therefore, the correct classification is PSI with high confidence.
2020-11-25 English
Form of Proxy for the Second H Shares Class Meeting of 2020
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Form of Proxy' for the Second H Shares Class Meeting of 2020 of Pharmaron Beijing Co., Ltd. It is a proxy voting form allowing shareholders to appoint a proxy to vote on their behalf at a specific shareholder meeting. The content includes instructions on how to fill out the proxy form, voting options for special resolutions, and procedural notes related to the meeting. There is no financial data, report content, or management discussion. This document is related to shareholder meeting voting procedures rather than the meeting materials or results themselves. Therefore, it fits best under the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2020-11-25 English
Form of Proxy for the Third Extraordinary General Meeting of 2020 (Applicable to H Shareholders)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for the Third Extraordinary General Meeting (EGM) of 2020 of Pharmaron Beijing Co., Ltd. It includes instructions for shareholders to appoint proxies to vote on various resolutions at the EGM, including special and ordinary resolutions. The content is focused on voting procedures and proxy appointments rather than the meeting's results or detailed reports. This type of document is typically classified as Proxy Solicitation & Information Statement (PSI), as it is sent to shareholders to provide information and request votes for the meeting. It is not a report of voting results (DVA), nor is it a report or announcement of financial or management information. The document length (6178 characters) and content confirm it is a proxy form, not a report publication announcement or regulatory filing.
2020-11-25 English
ADOPTION OF A SHARE INCENTIVE SCHEME AND ASSESSMENT MANAGEMENT MEASURES&#x3b; ISSUE AND GRANT OF A SHARES PURSUANT TO SPECIFIC MANDATE&#x3b; AUTHORIZATION TO HANDLE THE A SHARE INCENTIVE SCHEME&#x3b;
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed circular from Pharmaron Beijing Co., Ltd. regarding multiple proposed corporate actions including adoption of share incentive schemes, amendments to articles of association, change of supervisor, and notices of extraordinary general meeting (EGM) and class meeting. It includes definitions, detailed explanations of schemes, proxy forms, and notices for shareholder meetings. The presence of proxy forms, meeting notices, and detailed proposals for shareholder approval indicates this is a circular related to shareholder meetings and voting. It is not a financial report, earnings release, or audit report. It is not a simple announcement but a comprehensive document sent to shareholders to inform and solicit votes on corporate governance and capital structure matters. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs and class meetings.
2020-11-25 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.